Endothelial cell signature in muscle stem cells validated by VEGFA-FLT1-AKT1 axis promoting survival of muscle stem cell
eLife · 2024
DOI: 10.7554/elife.73592 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Mayank Verma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics & Neurology, Division of Pediatric Neurology, The University of Texas Southwestern Medical Center, Dallas, United States. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-1, Proto-Oncogene Proteins c-akt, Vascular Endothelial Growth Factor A, Signal Transduction. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAMS NIH HHS, Muscular Dystrophy Association.
Abstract (Originalsprache)
Endothelial and skeletal muscle lineages arise from common embryonic progenitors. Despite their shared developmental origin, adult endothelial cells (ECs) and muscle stem cells (MuSCs; satellite cells) have been thought to possess distinct gene signatures and signaling pathways. Here, we shift this paradigm by uncovering how adult MuSC behavior is affected by the expression of a subset of EC transcripts. We used several computational analyses including single-cell RNA-seq (scRNA-seq) to show that MuSCs express low levels of canonical EC markers in mice. We demonstrate that MuSC survival is regulated by one such prototypic endothelial signaling pathway (VEGFA-FLT1). Using pharmacological and genetic gain- and loss-of-function studies, we identify the FLT1-AKT1 axis as the key effector underlying VEGFA-mediated regulation of MuSC survival. All together, our data support that the VEGFA-FLT1-AKT1 pathway promotes MuSC survival during muscle regeneration, and highlights how the minor expression of select transcripts is sufficient for affecting cell behavior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics & Neurology, Division of Pediatric Neurology, The University of Texas Southwestern Medical Center, Dallas, United States.
- Stem Cell Institute, University of Minnesota Medical School, Minneapolis, United States.
- Greg Marzolf Jr. Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, United States.
- Department of Neurology, University of Minnesota Medical School, Minneapolis, United States.
- Department of Cell, Developmental, and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, United States.
- Graduate School of Biomedical Sciencesf, Icahn School of Medicine at Mount Sinai, New York, United States.
ORCID-Profile: Mayank Verma, Yoko Asakura, Allison P Kann, Robert S Krauss, Atsushi Asakura
Förderung
- NIH HHS
- NIAMS NIH HHS
- Muscular Dystrophy Association
- Regenerative Medicine Minnesota
- New York State Stem Cell Science
- NIGMS NIH HHS
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Verma, M., Asakura, Y., Wang, X., Zhou, K., Ünverdi, M., Kann, A. P., Krauss, R. S., & Asakura, A. (2024). Endothelial cell signature in muscle stem cells validated by VEGFA-FLT1-AKT1 axis promoting survival of muscle stem cell. eLife. https://doi.org/10.7554/elife.73592
Vancouver
Verma M, Asakura Y, Wang X, Zhou K, Ünverdi M, Kann AP, et al. Endothelial cell signature in muscle stem cells validated by VEGFA-FLT1-AKT1 axis promoting survival of muscle stem cell. eLife. 2024. doi:10.7554/elife.73592
BibTeX
@article{Verma2024,
author = {Verma, Mayank and Asakura, Yoko and Wang, Xuerui and Zhou, Kasey and Ünverdi, Mahmut and Kann, Allison P and Krauss, Robert S and Asakura, Atsushi},
title = {Endothelial cell signature in muscle stem cells validated by VEGFA-FLT1-AKT1 axis promoting survival of muscle stem cell},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.73592}
}
EUVIMED